HEADER TRANSFERASE(PHOSPHOTRANSFERASE) 21-SEP-91 1CPK OBSLTE 15-JAN-93 1CPK 2CPK TITLE CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CYCLIC TITLE 2 ADENOSINE MONOPHOSPHATE-*DEPENDENT PROTEIN KINASE COMPND MOL_ID: 1; COMPND 2 MOLECULE:; COMPND 3 CHAIN: E; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE:; COMPND 7 CHAIN: I; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 MOL_ID: 2 KEYWDS TRANSFERASE(PHOSPHOTRANSFERASE) EXPDTA X-RAY DIFFRACTION AUTHOR D.R.KNIGHTON,J.ZHENG,L.F.TENEYCK,V.A.ASHFORD,N.-H.XUONG, AUTHOR 2 S.S.TAYLOR,J.M.SOWADSKI REVDAT 2 15-JAN-93 1CPK 3 OBSLTE REVDAT 1 15-JAN-92 1CPK 0 JRNL AUTH D.R.KNIGHTON,J.ZHENG,L.F.TENEYCK, JRNL AUTH 2 V.A.ASHFORD N.-H.XUONG,S.S.TAYLOR,J.M.SOWADSKI JRNL TITL CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF JRNL TITL 2 CYCLIC ADENOSINE MONOPHOSPHATE-DEPENDENT PROTEIN JRNL TITL 3 KINASE JRNL REF SCIENCE V. 253 407 1991 JRNL REFN ASTM SCIEAS US ISSN 0036-8075 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.R.KNIGHTON,J.ZHENG,L.F.TENEYCK,N.-H.XUONG, REMARK 1 AUTH 2 S.S.TAYLOR,J.M.SOWADSKI REMARK 1 TITL STRUCTURE OF A PEPTIDE INHIBITOR BOUND TO THE REMARK 1 TITL 2 CATALYTIC SUBUNIT OF CYCLIC ADENOSINE REMARK 1 TITL 3 MONOPHOSPHATE-DEPENDENT PROTEIN KINASE REMARK 1 REF SCIENCE V. 253 414 1991 REMARK 1 REFN ASTM SCIEAS US ISSN 0036-8075 REMARK 1 REFERENCE 2 REMARK 1 AUTH L.W.SLICE,S.S.TAYLOR REMARK 1 TITL EXPRESSION OF THE CATALYTIC SUBUNIT OF REMARK 1 TITL 2 C/AMP-DEPENDENT PROTEIN KINASE IN ESCHERICHIA COLI REMARK 1 REF J.BIOL.CHEM. V. 264 20940 1989 REMARK 1 REFN ASTM JBCHA3 US ISSN 0021-9258 REMARK 2 REMARK 2 RESOLUTION. NULL ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : NULL REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2927 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 12 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1CPK COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 5 REMARK 5 1CPK THERE IS NO ELECTRON DENSITY FOR THE 14 N-TERMINAL REMARK 5 RESIDUES 1CPK OF THE CATALYTIC SUBUNIT, WHICH ARE PRESUMED REMARK 5 DISORDERED. 1CPK REMARK 6 REMARK 6 1CPK THE TWO C-TERMINAL RESIDUES (HIS I 19 AND ASP I 20) OF REMARK 6 THE 1CPK PEPTIDE INHIBITOR HAVE POOR ELECTRON DENSITY. 1CPK REMARK 7 REMARK 7 1CPK RESIDUES SER E 139, THR E 197, AND SER E 338 ARE 1CPK REMARK 7 PHOSPHORYLATED. THE PHOSPHATE GROUPS ARE PRESENTED ON 1CPK REMARK 7 *HETATM* RECORDS AT THE END OF THE CHAIN. 1CPK REMARK 8 REMARK 8 1CPK PLEASE NOTE DUE TO THE PRELIMINARY NATURE OF THE REMARK 8 REFINEMENT 1CPK THERE ARE A NUMBER OF RESIDUES WHOSE PSI/ REMARK 8 PHI VALUES LIE 1CPK OUTSIDE THE ALLOWED REGIONS IN THE REMARK 8 RAMACHANDRAN PLOT. 1CPK REMARK 9 REMARK 9 1CPK CORRECTION. THIS ENTRY IS OBSOLETE. 15-JAN-93. 1CPK REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.64 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 1/2-X,-Y,1/2+Z REMARK 290 3555 -X,1/2+Y,1/2-Z REMARK 290 4555 1/2+X,1/2-Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.81000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.07000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.26000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.07000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.81000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.26000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY E 1 REMARK 465 ASN E 2 REMARK 465 ALA E 3 REMARK 465 ALA E 4 REMARK 465 ALA E 5 REMARK 465 ALA E 6 REMARK 465 LYS E 7 REMARK 465 LYS E 8 REMARK 465 GLY E 9 REMARK 465 SER E 10 REMARK 465 GLU E 11 REMARK 465 GLN E 12 REMARK 465 GLU E 13 REMARK 465 SER E 14 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI REMARK 500 OG1 THR E 197 P PHO E 2 1.52 REMARK 500 OG SER E 139 P PHO E 1 1.68 REMARK 500 OG SER E 338 P PHO E 3 1.82 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE E 54 -53.54 51.17 REMARK 500 GLN E 242 107.88 128.69 REMARK 500 SER E 262 146.48 76.16 REMARK 500 ASP E 286 -99.16 117.07 REMARK 500 LYS E 309 -83.25 47.51 REMARK 500 THR E 324 139.63 34.19 REMARK 500 HIS I 19 126.35 63.29 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ILE E 315 PRO E 316 -78.27 REMARK 500 GLY E 320 PRO E 321 104.64 SEQRES 1 E 350 GLY ASN ALA ALA ALA ALA LYS LYS GLY SER GLU GLN GLU SEQRES 2 E 350 SER VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP PHE SEQRES 3 E 350 LEU LYS LYS TRP GLU ASP PRO SER GLN ASN THR ALA GLN SEQRES 4 E 350 LEU ASP GLN PHE ASP ARG ILE LYS THR LEU GLY THR GLY SEQRES 5 E 350 SER PHE GLY ARG VAL MET LEU VAL LYS HIS LYS GLU SER SEQRES 6 E 350 GLY ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN LYS SEQRES 7 E 350 VAL VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN GLU SEQRES 8 E 350 LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO PHE LEU VAL SEQRES 9 E 350 LYS LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU TYR SEQRES 10 E 350 MET VAL MET GLU TYR VAL ALA GLY GLY GLU MET PHE SER SEQRES 11 E 350 HIS LEU ARG ARG ILE GLY ARG PHE SER GLU PRO HIS ALA SEQRES 12 E 350 ARG PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU TYR SEQRES 13 E 350 LEU HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS PRO SEQRES 14 E 350 GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR ILE GLN VAL SEQRES 15 E 350 THR ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG THR SEQRES 16 E 350 TRP THR LEU CYS GLY THR PRO GLU TYR LEU ALA PRO GLU SEQRES 17 E 350 ILE ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP TRP SEQRES 18 E 350 TRP ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA GLY SEQRES 19 E 350 TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE TYR SEQRES 20 E 350 GLU LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER HIS SEQRES 21 E 350 PHE SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU LEU SEQRES 22 E 350 GLN VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS ASP SEQRES 23 E 350 GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA THR SEQRES 24 E 350 THR ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU ALA SEQRES 25 E 350 PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR SER SEQRES 26 E 350 ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL SER SEQRES 27 E 350 ILE ASN GLU LYS CYS GLY LYS GLU PHE THR GLU PHE SEQRES 1 I 20 THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR GLY SEQRES 2 I 20 ARG ARG ASN ALA ILE HIS ASP FTNOTE 1 RESIDUES SER E 139, THR E 197, AND SER E 338 ARE FTNOTE 1 PHOSPHORYLATED. FTNOTE 2 PRO E 316 AND PRO E 321 APPEAR TO BE CIS-PROLINES WITH FTNOTE 2 PEPTIDE TORSION ANGLES OF 281.73 AND 104.64 DEGREES. DUE FTNOTE 2 TO THE PRELIMINARY NATURE OF THE REFINEMENT, THIS FTNOTE 2 OBSERVATION HAS NOT YET BEEN CONFIRMED. HET PHO E 1 4 HET PHO E 2 4 HET PHO E 3 4 HETNAM PHO PHEOPHYTIN A FORMUL 3 PHO 3(C55 H74 N4 O5) HELIX 1 A PHE E 18 GLU E 31 1 14 HELIX 2 AB LEU E 40 GLN E 42 5NOT NOTED IN JRNL REF 3 HELIX 3 B LYS E 76 LYS E 81 1 6 HELIX 4 C ILE E 85 ALA E 97 1 13 HELIX 5 D MET E 128 ILE E 135 1 8 HELIX 6 E GLU E 140 SER E 159 1 20 HELIX 7 EF1 PRO E 202 TYR E 204 5NOT NOTED IN JRNL REF 3 HELIX 8 EF2 PRO E 207 ILE E 210 1NOT NOTED IN JRNL REF 4 HELIX 9 F VAL E 219 ALA E 233 1 15 HELIX 10 G PRO E 243 SER E 252 1 10 HELIX 11 H SER E 262 LEU E 272 1 11 HELIX 12 I VAL E 288 LYS E 292 1 5 HELIX 13 J TRP E 302 TYR E 306 1 5 HELIX 14 IA THR I 2 PHE I 6 1INHIBITOR N-TERMINAL HELIX 5 HELIX 15 IB GLY I 10 THR I 12 5NOT NOTED IN JRNL, REF 1 3 SHEET 1 A 5 PHE E 43 GLY E 50 0 SHEET 2 A 5 MET E 58 LYS E 63 -1 SHEET 3 A 5 HIS E 68 ASP E 75 -1 SHEET 4 A 5 ASN E 115 GLU E 121 -1 SHEET 5 A 5 LEU E 106 LYS E 111 -1 SHEET 1 B 2 LEU E 162 ILE E 163 0 SHEET 2 B 2 LEU E 172 ILE E 174 -1 SHEET 1 C 2 ILE E 180 VAL E 182 0 SHEET 2 C 2 LYS E 189 ARG E 190 -1 CRYST1 73.620 76.520 80.140 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013583 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013068 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012478 0.00000